Murine transgenic cells lacking DNA topoisomerase IIβ are resistant to acridines and mitoxantrone:: Analysis of cytotoxicity and cleavable complex formation

被引:82
作者
Errington, F
Willmore, E
Tilby, MJ
Li, L
Li, G
Li, W
Baguley, BC
Austin, CA
机构
[1] Newcastle Univ, Sch Biochem & Genet, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Newcastle Univ, Canc Res Unit, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[3] Newcastle Univ, Dept Child Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[4] Mem Sloan Kettering Canc Ctr, Dept Med Phys & Radiat Oncol, New York, NY 10021 USA
[5] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[6] Univ Auckland, Sch Med, Auckland Canc Soc Res Ctr, Auckland, New Zealand
关键词
D O I
10.1124/mol.56.6.1309
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Murine transgenic cell lines lacking DNA topoisomerase II (topo II)beta have been used to assess the importance of topo II beta as a drug target. Western blot analysis confirmed that the topo II beta -/- cell lines did not contain topo II beta protein. In addition, both the topo II beta +/+ and topo II beta -/- cell lines contained similar levels of topo II alpha protein. The trapped in agarose DNA immunostaining assay (TARDIS) was used to detect topo II alpha and beta cleavable complexes in topo II beta -/- and topo II beta +/+ cells. These results show that both topo II alpha and beta are in vivo targets for etoposide, mitoxantrone, and amsacrine (mAMSA) in topo II beta +/+ cells. As expected, only the alpha-isoform was targeted in topo II beta -/- cells. Clonogenic assays comparing the survival of topo II beta -/- and topo II beta +/+ cells were carried out to establish whether the absence of topo II beta caused drug resistance. Increased survival of topo II beta -/- cells compared with topo II beta +/+ cells was observed after treatment with amsacrine (mAMSA), methyl N-(4'-[9-acridinylamino]-2-methoxyphenyl) carbamate hydrochloride (AMCA), methyl N-(4'-[9-acridinylamino]- 2-methoxyphenyl) carbamate hydrochloride (mAMCA), mitoxantrone, and etoposide. These studies showed that topo II beta -/- cells were significantly more resistant to mAMSA, AMCA, mAMCA, and mitoxantrone, than topo II beta +/+ cells, indicating that topo II beta is an important target for the cytotoxic effects of these compounds.
引用
收藏
页码:1309 / 1316
页数:8
相关论文
共 41 条
[1]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[2]   EXPRESSION, DOMAIN-STRUCTURE, AND ENZYMATIC-PROPERTIES OF AN ACTIVE RECOMBINANT HUMAN DNA TOPOISOMERASE II-BETA [J].
AUSTIN, CA ;
MARSH, KL ;
WASSERMAN, RA ;
WILLMORE, E ;
SAYER, PJ ;
WANG, JC ;
FISHER, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (26) :15739-15746
[3]   NOVEL HELA TOPOISOMERASE-II IS THE II-BETA ISOFORM - COMPLETE CODING SEQUENCE AND HOMOLOGY WITH OTHER TYPE-II TOPOISOMERASES [J].
AUSTIN, CA ;
SNG, JH ;
PATEL, S ;
FISHER, LM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1172 (03) :283-291
[4]  
Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO
[5]  
2-Q
[6]   A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrine [J].
Baguley, BC ;
Leteurtre, F ;
Riou, JF ;
Finlay, GJ ;
Pommier, Y .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (02) :272-279
[7]   Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells [J].
Chen, CL ;
Fuscoe, JC ;
Liu, Q ;
Relling, MV .
BLOOD, 1996, 88 (06) :2210-2218
[8]   CLONING AND CHARACTERIZATION OF FULL-LENGTH CDNAS CODING FOR THE DNA TOPOISOMERASE-II-BETA FROM CHINESE-HAMSTER LUNG-CELLS SENSITIVE AND RESISTANT TO 9-OH-ELLIPTICINE [J].
DEREUDDRE, S ;
FREY, S ;
DELAPORTE, C ;
JACQUEMINSABLON, A .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1264 (02) :178-182
[9]  
Dereuddre S, 1997, CANCER RES, V57, P4301
[10]   TOPOISOMERASE-II IS A STRUCTURAL COMPONENT OF MITOTIC CHROMOSOME SCAFFOLDS [J].
EARNSHAW, WC ;
HALLIGAN, B ;
COOKE, CA ;
HECK, MMS ;
LIU, LF .
JOURNAL OF CELL BIOLOGY, 1985, 100 (05) :1706-1715